
The private equity offering from the ‘capable, pragmatic and service oriented’ Lydian sits within its corporate and finance team, and is experienced in handling a range of matters, from mid-market to large-scale international transactions. Team co-head Peter De Ryck is ’knowledgeable in his field, proactive‘ and noted for his specialised real estate expertise, while co-head Maxime Colle combines private equity, life sciences, and technology sector expertise. Co-head Florence Colpaert made partner in January 2024 and is a go-to for energy and telecoms clients.
Testimonials
Collated independently by Legal 500 research team.
‘The Lydian team is a full service firm which is very capable, pragmatic and service oriented. They have assisted us on several international matters in which we required a Belgian local counsel.’
‘I have been working with Peter de Ryck for several years now and it is always a pleasure to work with him and his team. He is knowledgeable in his field, proactive and invests in his long term relationships.’
Key clients
- Naxicap Partners
- House of HR (backed by Bain Capital and Naxicap Partners)
- White Bridge Investments
- Andera Partners
- Tikehau Ace Capital
- Carl Zeiss Ventures
- La Financière Patrimoniale d'Investissement (LFPI)
- European Dental Group (backed by Nordic)
- Northleaf Capital Partners
- Waterland Private Equity
- Hartree Partners
- Alantra
- IU Group – formerly Career Partner Group (backed by Oakley Capital)
- Zurich Global Ventures
- StoneCalibre
- Dense Air Limited (backed by Sidewalk Infrastructure Partners)
- DWK Life Sciences (backed by One Equity Partners)
- SteelCase Inc.
- Level Equity Growth
- Bundesrepublik Deutschland – Finanzagentur GmbH
- Ufenau Capital Partners
- Bencis Capital Partners
- TINC NV
- Bloom Equity Partners
- Trill Impact Ventures
- Eli Lilly
Work highlights
- Assisted Norwegian software giant Visma with the acquisition of Silverfin NV (and its subsidiaries).
- Assisted independent investment company Bencis with the auction sale of Ceban Pharmaceuticals, a growing international healthcare platform that provides pharmaceutical solutions for local healthcare providers in several European countries.
- Assisted Eli Lilly and Company in view of a Series A Financing Round in Augustine Therapeutics NV, a spin-off of the Vlaams Instituut voor Biotechnologie (VIB) and the University of Leuven.
Lawyers

Practice head
The lawyer(s) leading their teams.
Peter De Ryck, Maxime Colle, Florence Colpaert